ANN ARBOR, Mich., -August 31, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has begun the process to open a new production and research center in addition to its new domestic facility and its prospective operations in Vietnam.  This new location is being planned to work in collaboration with the Company’s ongoing production expansion in the United States and prospective production in Vietnam.  To accelerate the process of establishing the new facility, the Company has signed a contract with a team of biotechnology regulation experts with a proven track record of successfully introducing new biotechnologies.

“We are excited to begin this new relationship.  This move to create a third prospective production location has been a consistent element of our long term growth plan for spider silk technologies.  After a thorough assessment of potential locations and collaborators, I believe we have found the ideal location and partners for our planned third production facility,” said COO Jon Rice.  “The regional expertise in silk production and the appetite for ground breaking technology makes this a perfect complement to our plans in Vietnam and our new facility in Indiana.”

The Company’s announcement of its planned overseas expansion follows closely on the heels of the Company’s announcement that it has completed the build out of its new production facility in Indiana.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs signs contract for delivery of 2,000 mulberry trees

ANN ARBOR, Mich., -August 16, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has signed a contract for the delivery of 2,000 mulberry trees.  With the purchase of these trees, the Company will be able to significantly expand its US production of spider silk fibers including both Dragon Silk™ and Monster Silk®.  The Company is currently preparing for the planting of these first two thousand trees and is actively assessing its requirements for additional trees.

Mulberry leaves are an important dietary requirement for the Company’s proprietary transgenic silkworms which spin recombinant spider silk.   The planting of these trees is seen by the Company as the next step in expanding US production.

“The purchase of these trees is an important part of our plans to diversify our production both in the US and overseas. These trees will provide a sustainable, low cost, domestic input source for our US based silk production,” said COO Jon Rice.  “In addition to decreasing our costs and ensuring a stable food supply for our transgenic silkworms, testing in the laboratory has demonstrated that our silkworms produce better silk when fed fresh mulberry.”

The Company plans to use its US based production operations as an agile responsive capacity for domestic orders and as a testbed for future market developments.  This facility will work in parallel with the Company’s planned international high capacity operations.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs takes delivery of last piece of process equipment for the facility

ANN ARBOR, Mich., -August 9, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has completed the buildout of its new Indiana production facility ahead of schedule.   At this time the Company is installing the last piece of process equipment.  Over the next week the Company will complete all pre-production checks and plans to start bringing in silkworms the week of August 15.  This facility was initially established to fulfill the Company’s contract with the US Government.  Additional production capacity from this facility will be used to satisfy material needs from industry collaborators and pending customers.

“The Indiana production center represents our first domestic production expansion and is a major step towards our near term goal of a fully self-contained US spider silk production facility,” said COO Jon Rice.

“The opening of this facility is an exciting moment for Kraig Labs and the future of commercially sustainable spider silk production,” said CEO and Founder Kim Thompson.  “Our efforts in the lab have demonstrated the ability to recreate the incredible properties of spider silk, this facility now demonstrates that Kraig Labs can bring those materials to the market.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs catches the attention of international media with its progress in spider silk development

ANN ARBOR, Mich., – July 28, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)

(“Company”), the leading developer of spider silk based fibers, recent announcements regarding its planned increases in production capacity and Government contract for recombinant spider silk materials have generated significant media interest in spider silk.  These spider silk developments have been covered by numerous leading media outlets.

“Kraig Lab’s fibers are designed with a wide variety of applications and performance characteristics in mind, but, the most critical element of our design is our production methodology,” stated Jon Rice, COO.  “By utilizing silkworms to produce our recombinant spider silk we have created an incredibly efficient and low cost process to produce one of the toughest materials on Earth.  With the rapid growth of this technology over the last few years we are pleased to see the media taking such an interest in the market and applications for spider silk.”

Highlights of this coverage may be found at the following links;

All Outdoor: http://www.alloutdoor.com/2016/07/13/silkworms-will-make-ballistic-spider-silk-u-s-army/

Crains Detroit: http://www.crainsdetroit.com/article/20160712/NEWS/160719957/ann-arbor-company-wins-army-contract-for-spider-silk-material

The Daily Mail: http://www.dailymail.co.uk/sciencetech/article-3687263/US-soldiers-set-spidersuits-Artificial-webs-stronger-steel-tested-bulletproof-clothing.html

Defense One: http://www.defenseone.com/technology/2016/07/army-testing-genetically-engineered-spider-silk-body-armor/129814/

Executive Biz: http://blog.executivebiz.com/2016/07/army-taps-kraig-biocraft-to-develop-spider-silk-based-ballistic-shoot-packs/

Fox News: http://www.foxnews.com/tech/2016/07/19/us-army-eyes-dragon-silk-for-bullet-proof-vests.html

Gizmodo: http://gizmodo.com/the-army-wants-to-make-body-armor-out-of-genetically-en-1783507489

Govexec: http://www.govexec.com/defense/2016/07/army-testing-genetically-engineered-spider-silk-body-armor/129842/?oref=river

The Huffington Post: http://www.huffingtonpost.co.uk/entry/soldiers-could-soon-be-wearing-body-armour-made-from-genetically-engineered-spider-silk_uk_5786184be4b0f4bc594615f8

InfoWars: http://www.infowars.com/dragon-silk-pentagon-to-test-genetically-modified-silkworm-fiber-for-armor/

Innovations in Textiles: http://www.innovationintextiles.com/kraig-biocraft-laboratories-expands-domestic-spider-silk-production-with-indiana-facility/

Live Science: http://www.livescience.com/46519-spider-silk-bulletproof-clothing.html

New Indian Express: http://www.newindianexpress.com/world/US-Army-to-test-special-spider-silk-for-bullet-proof-gear/2016/07/18/article3535570.ece

Next Big Future: http://nextbigfuture.com/2016/07/us-army-is-testing-body-armor-made-from.html

Popular Mechanics: http://www.popularmechanics.com/military/research/a21793/army-body-armor-spider-silk/

South Front: https://southfront.org/us-army-to-test-armor-of-spider-silk-genetically-modified-silkworm-fiber/

SputnikNews: http://sputniknews.com/us/20160714/1042931976/army-silkworm-spider-body-armor.html

Tech Xplore: https://techxplore.com/news/2016-07-dragon-silk-army-material-elasticity.html

The Stashed: http://thestashed.com/2016/07/12/army-testing-genetically-engineered-spider-silk-body-armor/

Vocativ: http://www.vocativ.com/339502/spider-body-armor/

The Washington Times: http://www.washingtontimes.com/news/2016/jul/12/army-tests-genetically-engineered-spider-silk-for-/

Yahoo: https://www.yahoo.com/news/dragon-silk-armor-could-protect-us-troops-131725754.html

Disclaimer related to third party articles: The linked articles were produced independently by a third party with no affiliation with Kraig Biocraft Laboratories, Inc. (the “Company”).  The Company does not warrant any information produced by third parties.  Except for information provided by and attributed directly to the Company therein, these articles have been created without input or materials from the Company. The foregoing link has been provided for informational purposes only and the Company makes no representations as to the statements set forth therein and no investor should make an investment decision based on the article or without reviewing the Company’s reports filed with the Securities and Exchange Commission available on the Company website or at www.sec.gov.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,”

“foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs expands domestic spider silk production in response to increased demand

ANN ARBOR, Mich., -July 26, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the signing of a lease, and taking of possession, for its new production facility in Indiana.  The Company has already begun interior construction and expects to have the facility ready for operations by August 10, 2016.  This facility is expected to increase the Company’s US production capacity by nearly twenty times.  This facility will be used to fulfill the Company’s recently awarded contract from the US Government and to potentially supply additional collaborative textile developers.

“This expanded domestic capacity should allow us to be more responsive to customers in both capacity and variety of spider silk materials,” said COO Jon Rice.  “This growth of our production capacity will allow us to expand our relationships with both industry and governmental collaborators.  We are looking forward to the inauguration of this new production facility within the next two weeks.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -July 18, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that the Company has signed an office lease in Ho Chi Minh City, Vietnam.  The opening of the Company’s first overseas office is in keeping with its plans to expand silk production.  The establishment of this office is seen by the Company as an essential step in its efforts to obtain final approval from Vietnamese authorities for its planned hybrid silkworm research and pilot production operations.

“The new office is intended to provide an essential gateway for our long term plans which include establishing pilot production and advanced research in traditional silk producing regions.  From these humble beginnings we hope to build lasting relationships and spur economic growth,” said Company COO Jon Rice.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -July 12, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has received a contract valued at up to $1.0 million, if the option phase is awarded, for the development of high performance fibers for protective apparel applications. Under the fully funded base effort, valued at $99,962, the Company will deliver ballistic shoot packs constructed from its proprietary Dragon Silk™ material for performance testing.  These shoot packs will be tested and evaluated for critical Soldier protective applications including ballistic impact.  If awarded, the option phase will significantly expand this work with the US Army.

“Dragon Silk scores very highly in tensile strength and elasticity, which makes it one of the toughest fibers known to man and the ideal material for many applications,” stated Jon Rice, COO.  “Providing material for this ballistic shoot pack initiative is an important next step for Kraig and spider silk. This contract reinforces the many significant potential applications for recombinant spider silk. Today is a great day for spider silk.”

“We’re proud to be working with the Department of Defense to assess the exciting potential of spider silk for military applications,” stated Kim K Thompson, CEO and founder of Kraig Biocraft Laboratories. “We are honored that the U.S. Army has selected us for this program. This effort will provide Kraig Labs with the opportunity to validate our longstanding belief that spider silk technology has had an incredible potential for protective and lifesaving materials and expand our ability to design and engineer innovative materials solutions.”

The base effort on this contract is scheduled to last ten months and is the Company’s first US Department of Defense award.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,”

“foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Production Cost estimates Highlight the strategic positioning of Kraig’s Fibers

See the new report at: www.KraigLabs.com/comparison

ANN ARBOR, Mich., -June 7, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has published a new comparative analysis report featuring data related to the  global positioning of the company’s recombinant spider silk fibers.

“Given the various novel spider silk production techniques, management is extremely excited about how Kraig’s technology stacks up in this space.  Publishing this data is in line with our efforts to remain open and transparent as possible.  Our goal has always been to do more than just develop innovative wonder fibers. The results of this report reinforce our beliefs that we can deliver an outstanding value proposition for our customers, as well,” stated COO Jon Rice.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -May 24, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig”), the leading developer of spider silk based fibers, today announced that it has completed the biosafety and project risk assessment for its planned operations and subsidiary in Vietnam.  These documents were prepared in response to a request from the Vietnamese government to help them better understand the new technology the Company plans to introduce.  The Company is now waiting for document processing by the U.S. State Department and expects to send these documents to officials in Vietnam shortly.

“Completing this detailed review for Vietnam provided us with the opportunity to dive deep into our scale up plans,” said COO Jon Rice.  “By completing this process we have better prepared ourselves to begin operations in Vietnam or in any of the parallel production locations we are currently exploring.”

For the most recent edition of Kraig’s Spider Sense quarterly newsletter and to keep up with the latest news, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – May 16, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company is planning on establishing more than one additional production location, including domestic options, that would operate in parallel to its announced plans for operations in Vietnam.

The additional production sites will allow Kraig Labs to more rapidly fulfill outstanding material requests, from our collaboration partners and prospective clients, for recombinant spider silk fibers.

“Although securing a healthy supply of suitable mulberry leaves, to establish our domestic production, is a challenge, I believe that this initiative will yield many benefits, including enhancement of our R&D efforts.  Additionally, some of our end users may require that certain fibers are produced domestically, so this move places us ahead of that curve,” said COO Jon Rice.

For further information from the Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter/ 

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com